A new trading day began on Tuesday, with Entero Therapeutics Inc. (NASDAQ: ENTO) stock price up 3.45% from the previous day of trading, before settling in for the closing price of $0.40. ENTO’s price has ranged from $0.19 to $22.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
With a float of $3.16 million, this company’s outstanding shares have now reached $3.25 million.
Let’s look at the performance matrix of the company that is accounted for 9 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Entero Therapeutics Inc. (ENTO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Entero Therapeutics Inc. is 2.92%, while institutional ownership is 4.55%. The most recent insider transaction that took place on Jul 02 ’24, was worth 664. In this transaction Chief Financial Officer of this company sold 621 shares at a rate of $1.07, taking the stock ownership to the 18,490 shares. Before that another transaction happened on Jul 02 ’24, when Company’s Chairman and CEO sold 1,289 for $1.07, making the entire transaction worth $1,379. This insider now owns 35,816 shares in total.
Entero Therapeutics Inc. (ENTO) Latest Financial update
In its latest quarterly report, released on 3/31/2024, the company reported earnings of -37.8 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
Entero Therapeutics Inc. (NASDAQ: ENTO) Trading Performance Indicators
Here are Entero Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -49.23
Technical Analysis of Entero Therapeutics Inc. (ENTO)
Entero Therapeutics Inc. (NASDAQ: ENTO) saw its 5-day average volume 0.25 million, a negative change from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 42.65%. Additionally, its Average True Range was 0.08.
During the past 100 days, Entero Therapeutics Inc.’s (ENTO) raw stochastic average was set at 7.12%, which indicates a significant decrease from 77.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 123.19% in the past 14 days, which was lower than the 192.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6626, while its 200-day Moving Average is $3.2838. Nevertheless, the first resistance level for the watch stands at $0.4492 in the near term. At $0.4846, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5092. If the price goes on to break the first support level at $0.3892, it is likely to go to the next support level at $0.3646. The third support level lies at $0.3292 if the price breaches the second support level.
Entero Therapeutics Inc. (NASDAQ: ENTO) Key Stats
With a market capitalization of 1.34 million, the company has a total of 2,475K Shares Outstanding. Currently, annual sales are 0 K while annual income is -15,790 K. The company’s previous quarter sales were 0 K while its latest quarter income was 5,570 K.
